Cognome - Nome |
GURNARI Carmelo |
Posizione |
Ricercatore a tempo determinato - legge 240/10 art.24b |
Telefono |
+39 06 2090 2003 |
S.S.D. |
MED/15 – Malattie del sangue |
S.C. |
06/D3 – Malattie del sangue, Oncologia e Reumatologia |
e-mail |
|
Interessi di Ricerca |
• Sindromi mielodisplastiche • Sindrome VEXAS • Sindromi da insufficienza midollare • Leucemia mieloidi acute |
ESPERIENZA ACCADEMICA
Carmelo Gurnari è ricercatore in Ematologia presso il Dipartimento di Biomedicina e Prevenzione dell'Università di Roma Tor Vergata. Dopo essersi laureato presso la Facoltà di Medicina e Chirurgia di Pavia nel 2015 con una tesi in Ematologia/Oncologia Pediatrica, il Dott. Gurnari ha completato la sua formazione in Ematologia presso l'Università degli Studi di Roma, Tor Vergata. Ha poi deciso di continuare la sua formazione a Tor Vergata, ed è attualmente iscritto al corso di dottorato in "Immunologia, Medicina Molecolare e Biotecnologie Applicate". Allo stesso tempo, il Dr. Gurnari ha trascorso gli ultimi 3 anni lavorando presso il Dipartimento di Ematologia Traslazionale e Ricerca Oncologica della Cleveland Clinic (USA) dove si è concentrato sulla genomica delle sindromi da insufficienza midollare e delle neoplasie mieloidi. La sua esperienza di ricerca clinica e traslazionale comprende le neoplasie mieloidi con particolare attenzione alla leucemia promielocitica acuta, le sindromi mielodisplastiche, la sindrome VEXAS e la leucemia mieloide acuta. Il Dott. Gurnari è membro della European Hematology Association (EHA) per la quale è Mentor del Classical Master Class Program, e della European Society for Blood and Marrow Transplantation (EBMT), ed è attivamente coinvolto nelle attività della Trainee Committee e del Chronic Malignancies Working Party in qualità di vice-chair del sottocomitato MDS. È anche membro di altre società nazionali e internazionali come l'American Association for the Advancement of Science, la Società Italiana di Ematologia e di Ematologia Sperimentale e l'International Paroxysmal Nocturnal Hemoglobinuria Interest Group. In questi anni, il Dr. Gurnari ha ricevuto diversi premi internazionali come il Tito Bastianello Young Investigator Award nella ricerca sulle MDS e l'ASH-IPIG Award per la ricerca sulla PNH (2020 e 2022). Come si evince dai dati degli indici bibliometrici, il Dr. Gurnari è autore di oltre 80 pubblicazioni scientifiche indicizzate su SCOPUS/PubMed
ISTRUZIONE E FORMAZIONE
• EHA Classical Masterclass (2020)
• Post-doc fellowship in Translational Hematology and Oncology presso Cleveland Clinic, USA (2019-2023)
• Specializzazione in Ematologia, Tor Vergata (2020)
• Clinical fellowship presso Trapianto Emopoietico e Terapie Cellulari dell’Ospedale Pediatrico Bambino Gesu’ di Roma (2016)
• Laurea Specialistica in Medicine e Chirurgia, Università di Pavia (2015)
PUBBLICAZIONI SCIENTIFICHE
1. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Gurnari et al, JCO 2022
2. TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Gurnari et al, Blood Adv, 2021
3. Copper Definciency. Gurnari & Rogers, N Engl J Med. 2021
4. Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria. Gurnari et al, The Lancet, 2021
5. Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Gurnari et al, Blood 2021
6. Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. Gurnari et al, Br J Haematol 2021
Link PubMed profile: https://pubmed.ncbi.nlm.nih.gov/?term=gurnari+c&sort=date
Link SCOPUS: www.scopus.com/authid/detail.uri?authorId=57193087959
Carmelo Gurnari è ricercatore in Ematologia presso il Dipartimento di Biomedicina e Prevenzione dell'Università di Roma Tor Vergata. Dopo essersi laureato presso la Facoltà di Medicina e Chirurgia di Pavia nel 2015 con una tesi in Ematologia/Oncologia Pediatrica, il Dott. Gurnari ha completato la sua formazione in Ematologia presso l'Università degli Studi di Roma, Tor Vergata. Ha poi deciso di continuare la sua formazione a Tor Vergata, ed è attualmente iscritto al corso di dottorato in "Immunologia, Medicina Molecolare e Biotecnologie Applicate". Allo stesso tempo, il Dr. Gurnari ha trascorso gli ultimi 3 anni lavorando presso il Dipartimento di Ematologia Traslazionale e Ricerca Oncologica della Cleveland Clinic (USA) dove si è concentrato sulla genomica delle sindromi da insufficienza midollare e delle neoplasie mieloidi. La sua esperienza di ricerca clinica e traslazionale comprende le neoplasie mieloidi con particolare attenzione alla leucemia promielocitica acuta, le sindromi mielodisplastiche, la sindrome VEXAS e la leucemia mieloide acuta. Il Dott. Gurnari è membro della European Hematology Association (EHA) per la quale è Mentor del Classical Master Class Program, e della European Society for Blood and Marrow Transplantation (EBMT), ed è attivamente coinvolto nelle attività della Trainee Committee e del Chronic Malignancies Working Party in qualità di vice-chair del sottocomitato MDS. È anche membro di altre società nazionali e internazionali come l'American Association for the Advancement of Science, la Società Italiana di Ematologia e di Ematologia Sperimentale e l'International Paroxysmal Nocturnal Hemoglobinuria Interest Group. In questi anni, il Dr. Gurnari ha ricevuto diversi premi internazionali come il Tito Bastianello Young Investigator Award nella ricerca sulle MDS e l'ASH-IPIG Award per la ricerca sulla PNH (2020 e 2022). Come si evince dai dati degli indici bibliometrici, il Dr. Gurnari è autore di oltre 80 pubblicazioni scientifiche indicizzate su SCOPUS/PubMed
ISTRUZIONE E FORMAZIONE
• EHA Classical Masterclass (2020)
• Post-doc fellowship in Translational Hematology and Oncology presso Cleveland Clinic, USA (2019-2023)
• Specializzazione in Ematologia, Tor Vergata (2020)
• Clinical fellowship presso Trapianto Emopoietico e Terapie Cellulari dell’Ospedale Pediatrico Bambino Gesu’ di Roma (2016)
• Laurea Specialistica in Medicine e Chirurgia, Università di Pavia (2015)
PUBBLICAZIONI SCIENTIFICHE
1. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Gurnari et al, JCO 2022
2. TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Gurnari et al, Blood Adv, 2021
3. Copper Definciency. Gurnari & Rogers, N Engl J Med. 2021
4. Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria. Gurnari et al, The Lancet, 2021
5. Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Gurnari et al, Blood 2021
6. Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. Gurnari et al, Br J Haematol 2021
Link PubMed profile: https://pubmed.ncbi.nlm.nih.gov/?term=gurnari+c&sort=date
Link SCOPUS: www.scopus.com/authid/detail.uri?authorId=57193087959
Family Name- Name |
GURNARI Carmelo |
Position |
Researcher – Assistant Professor |
Telefono |
+39 06 7259 2003 |
S.S.D. |
MED/15 – Blood disorders |
S.C. |
06/D3 – Blood disorders, Oncology and Rheumatology |
e-mail |
ACADEMIC EXPERIENCE
Carmelo Gurnari is an Assistant Professor in Hematology at the Department of Biomedicine and Prevention of the University of Rome Tor Vergata. After graduating from Pavia (Italy) medical school in 2015 with a thesis on Pediatric Hematology/Oncology, Dr. Gurnari completed his training in Hematology at the University of Rome, Tor Vergata. He then decided to continue his education at Tor Vergata, and he is currently enrolled in a Ph.D program in "Immunology, Molecular Medicine and Applied Biotechnology". Simultaneously, Dr. Gurnari has spent the last 3 years working at the Department of Translational Hematology and Oncology Research of Cleveland Clinic (USA) where he has been focusing on the genomics of bone marrow failure disorders and myeloid neoplasia. His clinical and translational research expertise encompasses myeloid malignancies with a special focus on acute promyelocytic leukemia, myelodysplastic syndromes, VEXAS, and acute myeloid leukemia. Dr. Gurnari is a member of the European Hematology Association (EHA) for which serves as a Mentor of the Classical Master Class Program, and of the European Society for Blood and Marrow Transplantation (EBMT), and he is actively involved in the activities of the Trainee Committee and Chronic Malignancies Working Party as vice-chair of the MDS subcommittee. He is also a member of other national and international societies such as the American Association for the Advancement of Science, the Italian Hematology Association and the International Paroxysmal Nocturnal Hemoglobinuria Interest Group. In these years, Dr. Gurnari has been awarded several international prizes such as the Tito Bastianello Young Investigator Award in MDS research and the ASH-IPIG Award for PNH research (2020 and 2022). As can be deduced from the bibliometric indexes data, Carmelo Gurnari is author of over 80 scientific publications indexed on SCOPUS/PubMed.
EDUCATION
• EHA Classical Masterclass (2020)
• Post-doc fellowship in Translational Hematology and Oncology Research at Cleveland Clinic, USA (2019-2023)
• Hematology specialization, Tor Vergata University (2020)
• Clinical fellowship in Pediatric Hematology/Oncology and Bone Marrow Transplant Unit of Ospedale Pediatrico Bambino Gesu’ of Rome, Italy (2016)
• MD degree, University of Pavia (2015)
SCIENTIFIC PUBLICATIONS
1. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Gurnari et al, JCO 2022
2. TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Gurnari et al, Blood Adv, 2021
3. Copper Definciency. Gurnari & Rogers, N Engl J Med. 2021
4. Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria. Gurnari et al, The Lancet, 2021
5. Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Gurnari et al, Blood 2021
6. Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. Gurnari et al, Br J Haematol 2021
Link PubMed profile: https://pubmed.ncbi.nlm.nih.gov/?term=gurnari+c&sort=date
Link SCOPUS: www.scopus.com/authid/detail.uri?authorId=57193087959
Carmelo Gurnari is an Assistant Professor in Hematology at the Department of Biomedicine and Prevention of the University of Rome Tor Vergata. After graduating from Pavia (Italy) medical school in 2015 with a thesis on Pediatric Hematology/Oncology, Dr. Gurnari completed his training in Hematology at the University of Rome, Tor Vergata. He then decided to continue his education at Tor Vergata, and he is currently enrolled in a Ph.D program in "Immunology, Molecular Medicine and Applied Biotechnology". Simultaneously, Dr. Gurnari has spent the last 3 years working at the Department of Translational Hematology and Oncology Research of Cleveland Clinic (USA) where he has been focusing on the genomics of bone marrow failure disorders and myeloid neoplasia. His clinical and translational research expertise encompasses myeloid malignancies with a special focus on acute promyelocytic leukemia, myelodysplastic syndromes, VEXAS, and acute myeloid leukemia. Dr. Gurnari is a member of the European Hematology Association (EHA) for which serves as a Mentor of the Classical Master Class Program, and of the European Society for Blood and Marrow Transplantation (EBMT), and he is actively involved in the activities of the Trainee Committee and Chronic Malignancies Working Party as vice-chair of the MDS subcommittee. He is also a member of other national and international societies such as the American Association for the Advancement of Science, the Italian Hematology Association and the International Paroxysmal Nocturnal Hemoglobinuria Interest Group. In these years, Dr. Gurnari has been awarded several international prizes such as the Tito Bastianello Young Investigator Award in MDS research and the ASH-IPIG Award for PNH research (2020 and 2022). As can be deduced from the bibliometric indexes data, Carmelo Gurnari is author of over 80 scientific publications indexed on SCOPUS/PubMed.
EDUCATION
• EHA Classical Masterclass (2020)
• Post-doc fellowship in Translational Hematology and Oncology Research at Cleveland Clinic, USA (2019-2023)
• Hematology specialization, Tor Vergata University (2020)
• Clinical fellowship in Pediatric Hematology/Oncology and Bone Marrow Transplant Unit of Ospedale Pediatrico Bambino Gesu’ of Rome, Italy (2016)
• MD degree, University of Pavia (2015)
SCIENTIFIC PUBLICATIONS
1. Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. Gurnari et al, JCO 2022
2. TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Gurnari et al, Blood Adv, 2021
3. Copper Definciency. Gurnari & Rogers, N Engl J Med. 2021
4. Chronic Budd-Chiari syndrome in paroxysmal nocturnal haemoglobinuria. Gurnari et al, The Lancet, 2021
5. Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Gurnari et al, Blood 2021
6. Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters. Gurnari et al, Br J Haematol 2021
Link PubMed profile: https://pubmed.ncbi.nlm.nih.gov/?term=gurnari+c&sort=date
Link SCOPUS: www.scopus.com/authid/detail.uri?authorId=57193087959
|
Dipartimento di Biomedicina e Prevenzione
Department Biomedicine and Prevention Facoltà di Medicine e Chirurgia Faculty of Medicine and Surgery Università di Roma Tor Vergata University of Rome Tor Vergata Indirizzo/Address: Viale Montpellier, 1 – Roma (Studio D12) |
Direttore del Dipartimento / Director of the Department Prof. Antonio De Lorenzo Responsabile Amministrativo / Administrative Head Avv. Ombretta Picchioni Content manager del sito / Content manager of the website Prof. Andrea Malizia |